Showing results (81-90 of 118) with videos related to
Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|January 1, 1988
Uridine pharmacokinetics in cancer patientsT C Chan, M Markman, C E Pfeifle, et al.Leukemia|May 1, 1994
Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndromeB Glinsmann-Gibson, C Spier, M Baier, et al.Journal of Natural Products|September 1, 1996
(Hydroxymethyl)acylfulvene: an illudin derivative with superior antitumor propertiesT C McMorris, M J Kelner, W Wang, et al.Journal of the National Cancer Institute|March 16, 1994
Effects of combined antigrowth factor receptor treatment on in vitro growth of multiple myelomaR Taetle, B Dos Santos, Y Ohsugi, et al.Journal of Theoretical Biology|October 13, 2001
Graph models of oncogenesis with an application to melanomaM D Radmacher, R Simon, R Desper, et al.Anticancer Research|May 1, 1995
Nonresponsiveness of the metastatic human lung carcinoma MV522 xenograft to conventional anticancer agentsM J Kelner, T C McMorris, L Estes, et al.Blood|November 14, 1997
Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndromeA F List, F Brasfield, R Heaton, et al.Experientia|January 16, 1996
Acylfulvenes, a new class of potent antitumor agentsT C McMorris, M J Kelner, W Wang, et al.Blood|August 15, 1994
Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocationsM Russell, A List, P Greenberg, et al.European Journal of Cancer (Oxford, England : 1990)|November 3, 1998
Efficacy of MGI 114 (6-hydroxymethylacylfulvene, HMAF) against the mdr1/gp170 metastatic MV522 lung carcinoma xenograftM J Kelner, T C McMorris, L Estes, et al.Pageof 12